The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome
Open accessAbstract
Background & Aims Multigene panels are commercially available tools for hereditary cancer risk assessment that allow for next-generation sequencing of numerous genes in parallel. However, it is not clear if these panels offer advantages over traditional genetic testing. We investigated the number of cancer predisposition gene mutations identified by parallel sequencing in individuals with suspected Lynch syndrome. Methods We performed germline analysis with a 25-gene next-generation sequencing panel using DNA from 1260 individuals who underwent clinical genetic testing for Lynch syndrome from 2012 through 2013. All subjects had a history of Lynch syndrome-associated cancer and/or polyps. We classified all identified germline alterations for pathogenicity and calculated the frequencies of pathogenic mutations and variants of uncertain significance (VUS). We also analyzed data on patients’ personal and family history of cancer, including fulfillment of clinical guidelines for genetic testing. Results Of the 1260 subjects, 1112 met National Comprehensive Cancer Network (NCCN) criteria for Lynch syndrome testing (88%; 95% confidence interval [CI], 86%–90%). Multigene panel testing identified 114 probands with Lynch syndrome mutations (9.0%; 95% CI, 7.6%−10.8%) and 71 with mutations in other cancer predisposition genes (5.6%; 95% CI, 4.4%−7.1%). Fifteen individuals had mutations in BRCA1 or BRCA2; 93% of these met the NCCN criteria for Lynch syndrome testing and 33% met NCCN criteria for BRCA1 and BRCA2 analysis (P=.0017). An additional 9 individuals carried mutations in other genes linked to high lifetime risks of cancer (5 had mutations in APC, 3 had bi-allelic mutations in MUTYH, and 1 had a mutation in STK11); all of these patients met NCCN criteria for Lynch syndrome testing. Four hundred seventy-nine individuals had ≥1 VUS (38%; 95% CI, 35%–41%). Conclusions In individuals with suspected Lynch syndrome, multigene panel testing identified high-penetrance mutations in cancer predisposition genes, many of which were unexpected based on patients’ histories. Parallel sequencing also detected a high number of potentially uninformative germline findings, including VUS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
VASEN, H., WATSON, P., MECKLIN, J., & LYNCH, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70510-x · Cited by 2,519
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Landon, M., Saam, J., Brown, K. L., Moyes, K., Evans, B., & Wenstrup, R. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,939
Self-citationSaam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Self-citationInherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
Al-Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N., Livingston, A. L., Williams, G. T., Hodges, A. K., Davies, D. R., David, S. S., Sampson, J. R., et al. (2002) · Nature Genetics · doi:10.1038/ng828 · Cited by 1,394
Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70168-5 · Cited by 1,337
Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Clendenning, M., Sotamaa, K., Prior, T., Westman, J. A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5950 · Cited by 876
Richards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E., & Ward, B. E. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b5cae · Cited by 832
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Self-citationVasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Identification of Lynch Syndrome Among Patients With Colorectal Cancer
Moreira, L., Balaguer, F., Lindor, N., de la Chapelle, A., Hampel, H., Aaltonen, L. A., Hopper, J. L., Le Marchand, L., Gallinger, S., Newcomb, P. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.13088 · Cited by 556
The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations
Senter, L., Clendenning, M., Sotamaa, K., Hampel, H., Green, J., Potter, J. D., Lindblom, A., Lagerstedt, K., Thibodeau, S. N., Lindor, N. M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.026 · Cited by 550
Lindor, N. M., Rabe, K., Petersen, G. M., Haile, R., Casey, G., Baron, J., Gallinger, S., Bapat, B., Aronson, M., Hopper, J., et al. (2005) · JAMA · doi:10.1001/jama.293.16.1979 · Cited by 546
Risk of Pancreatic Cancer in Families With Lynch Syndrome
Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544
Fitzgerald, R. C., Hardwick, R., Huntsman, D., Carneiro, F., Guilford, P., Blair, V., Chung, D. C., Norton, J., Ragunath, K., Van Krieken, J. H., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.074237 · Cited by 542
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
Palomaki, G. E., McClain, M. R., Melillo, S., Hampel, H. L., & Thibodeau, S. N. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e31818fa2db · Cited by 467
Easton, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
Self-citationAutosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH
Sampson, J. R., Dolwani, S., Jones, S., Eccles, D., Ellis, A., Evans, D. G., Frayling, I., Jordan, S., Maher, E. R., Mak, T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13805-6 · Cited by 442
Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K., Timms, K., Garber, J. E., Herold, C., Ellisen, L., et al. (2015) · Cancer · doi:10.1002/cncr.29010 · Cited by 430
Self-citationJones, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.23.2961 · Cited by 400
Dominant Negative ATM Mutations in Breast Cancer Families
Chenevix-Trench, G. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.205 · Cited by 376
Koonin, E. V., Altschul, S. F., & Bork, P. (1996) · Nature Genetics · doi:10.1038/ng0796-266 · Cited by 368
Hall, M. J., Reid, J. E., Burbidge, L. A., Pruss, D., Deffenbaugh, A. M., Frye, C., Wenstrup, R. J., Ward, B. E., Scholl, T. A., & Noll, W. W. (2009) · Cancer · doi:10.1002/cncr.24200 · Cited by 365
Self-citationStructure of the Human MutSα DNA Lesion Recognition Complex
Warren, J. J., Pohlhaus, T. J., Changela, A., Iyer, R. R., Modrich, P. L., & Beese, L. S. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.018 · Cited by 362
hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.
Liu, B., Parsons, R. E., Hamilton, S. R., Petersen, G. M., Lynch, H. T., Watson, P., Markowitz, S. D., Willson, J. K. V., Green, J., & de la Chapelle, A. (1994) · PubMed · Cited by 360
Win, A. K., Young, J. P., Lindor, N. M., Tucker, K. M., Ahnen, D. J., Young, G. P., Buchanan, D. D., Clendenning, M., Giles, G. G., Winship, I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.5590 · Cited by 333
Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1684 · Cited by 319
Association Between Biallelic and Monoallelic Germline MYH Gene Mutations and Colorectal Cancer Risk
Croitoru, M. E., Cleary, S. P., Di Nicola, N., Manno, M., Selander, T., Aronson, M., Redston, M., Cotterchio, M., Knight, J., Gryfe, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh288 · Cited by 259
Levy, D. E., Byfield, S. D., Comstock, C. B., Garber, J. E., Syngal, S., Crown, W. H., & Shields, A. E. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182091ba4 · Cited by 242
Self-citationMultiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Domchek, S. M., Bradbury, A., Garber, J. E., Offit, K., & Robson, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9403 · Cited by 237
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1
Williams, R. S., Lee, M. S., Hau, D. D., & Glover, J. N. M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb776 · Cited by 230
Clinical Implications of the Colorectal Cancer Risk Associated With MUTYH Mutation
Lubbe, S. J., Di Bernardo, M. C., Chandler, I. P., & Houlston, R. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6853 · Cited by 224
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Chang, S., Wang, R.-H., Akagi, K., Kim, K.-A., Martin, B. K., Cavallone, L., Haines, D. C., Basik, M., Mai, P., et al. (2011) · Nature Medicine · doi:10.1038/nm.2459 · Cited by 224
Functional analysis of hMLH1 variants and HNPCC-related mutations using a human expression system
Trojan, J., Zeuzem, S., Randolph, A., Hemmerle, C., Brieger, A., Raedle, J., Plotz, G., Jiricny, J., & Marra, G. (2002) · Gastroenterology · doi:10.1053/gast.2002.30296 · Cited by 212
Beamer, L. C., Grant, M. L., Espenschied, C. R., Blazer, K. R., Hampel, H. L., Weitzel, J. N., & MacDonald, D. J. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4719 · Cited by 202
Functional Significance and Clinical Phenotype of Nontruncating Mismatch Repair Variants of MLH1
Raevaara, T. E., Korhonen, M. K., Lohi, H., Hampel, H., Lynch, E., Lönnqvist, K. E., Holinski-Feder, E., Sutter, C., McKinnon, W., Duraisamy, S., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.005 · Cited by 197
Pérez-Carbonell, L., Ruiz-Ponte, C., Guarinos, C., Alenda, C., Payá, A., Brea, A., Egoavil, C. M., Castillejo, A., Barberá, V. M., Bessa, X., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300041 · Cited by 191
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
Metcalfe, K. A., Poll, A., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P., & Narod, S. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0712 · Cited by 190
Eggington, J. M., Bowles, K. R., Moyes, K., Manley, S., Esterling, L., Sizemore, S., Rosenthal, E., Theisen, A., Saam, J., Arnell, C., et al. (2014) · Clinical Genetics · doi:10.1111/cge.12315 · Cited by 188
Self-citationGoldgar, D. E., Easton, D. F., Byrnes, G. B., Spurdle, A. B., Iversen, E. S., Greenblatt, M. S., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20897 · Cited by 188
Kastrinos, F., Steyerberg, E. W., Mercado, R., Balmaña, J., Holter, S., Gallinger, S., Siegmund, K. D., Church, J. M., Jenkins, M. A., Lindor, N. M., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.08.021 · Cited by 184
Self-citationGenome-Wide Association Studies of Cancer
Stadler, Z. K., Thom, P., Robson, M. E., Weitzel, J. N., Kauff, N. D., Hurley, K. E., Devlin, V., Gold, B., Klein, R. J., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7816 · Cited by 183
Nakagawa, H., Lockman, J. C., Frankel, W. L., Hampel, H., Steenblock, K., Burgart, L. J., Thibodeau, S. N., & de la Chapelle, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2879 · Cited by 166
Tournier, I., Vezain, M., Martins, A., Charbonnier, F., Baert-Desurmont, S., Olschwang, S., Wang, Q., Buisine, M. P., Soret, J., Tazi, J., et al. (2008) · Human Mutation · doi:10.1002/humu.20796 · Cited by 163
Gene Panel Testing for Inherited Cancer Risk
Hall, M. J., Forman, A. D., Pilarski, R., Wiesner, G. L., & Giri, V. N. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0128 · Cited by 159
Cancer Genomics and Inherited Risk
Stadler, Z. K., Schrader, K. A., Vijai, J., Robson, M. E., & Offit, K. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7271 · Cited by 159
Balaguer, F., Castellvı́-Bel, S., Castells, A., Andreu, M. G., Muñoz, J., Gisbert, J. P., Llor, X., Jover, R., de Cid, R., Gonzalo, V., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.025 · Cited by 151
The BRCA1 C-terminal domain: structure and function
Huyton, T., Bates, P. A., Zhang, X., Sternberg, M. J. E., & Freemont, P. S. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00034-3 · Cited by 147
Foulkes, W. D., Thiffault, I., Gruber, S. B., Horwitz, M. S., Hamel, N., Lee, C., Shia, J., Markowitz, A. J., Figer, A., Friedman, E., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/345075 · Cited by 133
Increased Colorectal Cancer Incidence in Obligate Carriers of Heterozygous Mutations in MUTYH
Jones, N., Vogt, S. L., Nielsen, M., Christian, D., Wark, P. A., Eccles, D., Edwards, E., Evans, D. G., Maher, E. R., Vasen, H. F. A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.047 · Cited by 132
Gallego, C. J., Shirts, B. H., Bennette, C. S., Guzauskas, G. F., Amendola, L. M., Horike-Pyne, M. J., Hisama, F. M., Pritchard, C. C., Grady, W. M., Burke, W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.3665 · Cited by 126
Judkins, T., Leclair, B., Bowles, K., Gutin, N., Trost, J., McCulloch, J., Bhatnagar, S., Murray, A., Craft, J., Wardell, B., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1224-y · Cited by 118
Self-citationBernstein, J. L., Teraoka, S. N., Southey, M. C., Jenkins, M. A., Andrulis, I. L., Knight, J. A., John, E. M., Lapinski, R. H., Wolitzer, A. L., Whittemore, A. S., et al. (2006) · Human Mutation · doi:10.1002/humu.20415 · Cited by 118
Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer
Win, A. K., Cleary, S. P., Dowty, J. G., Baron, J. A., Young, J. P., Buchanan, D. D., Southey, M. C., Burnett, T. S., Parfrey, P. S., Green, R. C., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25870 · Cited by 108
Structure-Based Assessment of Missense Mutations in Human BRCA1
Mirkovic, N., Martí-Renom, M., Weber, B., Sali, A., & Monteiro, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3009 · Cited by 105
Conversion Analysis for Mutation Detection in MLH1 and MSH2 in Patients With Colorectal Cancer
Casey, G. (2005) · JAMA · doi:10.1001/jama.293.7.799 · Cited by 104
Genetic and clinical characterisation of familial adenomatous polyposis: a population based study
Al, M., Järvinen, H., & Peltomäki, P. (2002) · Gut · doi:10.1136/gut.50.6.845 · Cited by 97
Sampson, J. R., & Jones, N. (2009) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2009.03.006 · Cited by 95
Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants
Pagenstecher, C., Wehner, M., Friedl, W., Rahner, N., Aretz, S., Friedrichs, N., Sengteller, M., Henn, W., Buettner, R., Propping, P., et al. (2005) · Human Genetics · doi:10.1007/s00439-005-0107-8 · Cited by 94
Auclair, J., Buisine, M., Navarro, C., Ruano, E., Montmain, G., Desseigne, F., Saurin, J. C., Lasset, C., Bonadona, V., Giraud, S., et al. (2006) · Human Mutation · doi:10.1002/humu.20280 · Cited by 90
Population-Based Molecular Screening for Lynch Syndrome: Implications for Personalized Medicine
Ward, R. L., Hicks, S. C., & Hawkins, N. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8454 · Cited by 89
Clinical analysis ofPMS2: mutation detection and avoidance of pseudogenes
Vaughn, C. P., Robles, J., Swensen, J. J., Miller, C. E., Lyon, E., Mao, R., Bayrak‐Toydemir, P., & Samowitz, W. S. (2010) · Human Mutation · doi:10.1002/humu.21230 · Cited by 88
McClain, M. R., Palomaki, G. E., Nathanson, K. L., & Haddow, J. E. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000151155.36470.ff · Cited by 85
Cragun, D. L., DeBate, R. D., Vadaparampil, S. T., Baldwin, J. A., Hampel, H., & Pal, T. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.31 · Cited by 85
Genetic Testing by Cancer Site
Chun, N., & Ford, J. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e31826246dc · Cited by 84
Lovelock, P. K., Spurdle, A. B., Mok, M. T. S., Farrugia, D. J., Lakhani, S. R., Healey, S. C., Arnold, S., Buchanan, D. D., kConFab Investigators, Couch, F. J., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1826 · Cited by 84
Prevalence of germline MUTYH mutations among Lynch-like syndrome patients
Castillejo, A., Vargas‐Parra, G., Castillejo, M. I., Navarro, M., Barberá, V. M., González, S., Hernández‐Illán, E., Brunet, J., y Cajal, T. R., Balmañà, J., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.05.022 · Cited by 81
Genetic Counseling Considerations in the Evaluation of Families for Lynch Syndrome—A Review
Weissman, S. M., Bellcross, C. A., Bittner, C. C., Freivogel, M. E., Haidle, J. L., Kaurah, P., Leininger, A., Palaniappan, S., Steenblock, K. J., Vu, T. M., et al. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9325-x · Cited by 81
Auclair, J., Leroux, D., Desseigne, F., Lasset, C., Saurin, J. C., Joly, M. O., Pinson, S., Xu, X. L., Montmain, G., Ruano, E., et al. (2007) · Human Mutation · doi:10.1002/humu.20569 · Cited by 73
Mohammadi, L., Vreeswijk, M. P. G., Oldenburg, R. A., van den Ouweland, A., Oosterwijk, J. C., van der Hout, A. H., Hoogerbrugge, N., Ligtenberg, M. J. L., Ausems, M. G. E. M., van der Luijt, R. B., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-211 · Cited by 70
Evidence for accelerated colorectal adenoma–carcinoma progression in MUTYH -associated polyposis?
Nieuwenhuis, M. H., Vogt, S. L., Jones, N., Nielsen, M., Hes, F. J., Sampson, J. R., Aretz, S., & Vasen, H. F. A. (2011) · Gut · doi:10.1136/gut.2010.229104 · Cited by 64
Kastrinos, F., Steyerberg, E. W., Balmañà, J., Mercado, R. C., Gallinger, S., Haile, R. W., Casey, G., Hopper, J. L., Marchand, L. L., Lindor, N. M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301265 · Cited by 53
Self-citationRisk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers
Mukherjee, B., DeLancey, J. O., Raskin, L., Everett, J., Jeter, J., Begg, C. B., Orlow, I., Berwick, M., Armstrong, B. K., Kricker, A., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs221 · Cited by 42
Robson, M. E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.0474 · Cited by 39
Mester, J. L., Moore, R. A., & Eng, C. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0174 · Cited by 29
Nine novel pathogenic germline mutations inMLH1,MSH2,MSH6andPMS2in families with Lynch syndrome
Rahner, N., Friedrichs, N., Wehner, M., Steinke, V., Aretz, S., Friedl, W., Buettner, R., Mangold, E., Propping, P., & Walldorf, C. (2007) · Acta Oncologica · doi:10.1080/02841860701230217 · Cited by 17
MUTYH hotspot mutations in unselected colonoscopy patients
Casper, M., Plotz, G., Juengling, B., et al. (2012) · Colorectal Disease · doi:10.1111/j.1463-1318.2012.02920.x · Cited by 13
Cited by
Pearlman, R., Frankel, W. L., Swanson, B., Zhao, W., Yilmaz, A., Miller, K., Bacher, J., Bigley, C., Nelsen, L., Goodfellow, P. J., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5194 · Cited by 707
Self-citationIncreasing Incidence of Early-Onset Colorectal Cancer
Sinicrope, F. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2200869 · Cited by 534
Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Yurgelun, M. B., Kulke, M. H., Fuchs, C. S., Allen, B. A., Uno, H., Hornick, J. L., Ukaegbu, C. I., Brais, L. K., McNamara, P. G., Mayer, R. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0012 · Cited by 524
Self-citationNext-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification
Kamps, R., Brandão, R., Bosch, B., Paulussen, A., Xanthoulea, S., Blok, M., & Romano, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020308 · Cited by 453
Germline Genetic Features of Young Individuals With Colorectal Cancer
Stoffel, E. M., Koeppe, E., Everett, J., Ulintz, P., Kiel, M., Osborne, J., Williams, L., Hanson, K., Gruber, S. B., & Rozek, L. S. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.004 · Cited by 333
Metadata
- Authors
- Yurgelun, M. B., Allen, B., Kaldate, R. R., Bowles, K. R., Judkins, T., Kaushik, P., Roa, B. B., Wenstrup, R. J., Hartman, A.-R., & Syngal, S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 149
- Issue
- 3
- Pages
- 604-613.e20
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1638580279
- Cited by
- 260
- References
- 82
- FWCI
- 22.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.